Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.07
+0.28001.01%
Pre-market: 28.130.0601+0.21%08:37 EDT
Volume:37.11M
Turnover:1.04B
Market Cap:159.60B
PE:36.94
High:28.43
Open:27.77
Low:27.66
Close:27.79
52wk High:28.75
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:1.05
T/O Rate:0.66%
Dividend:1.72
Dividend Rate:6.13%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.87
PE(LYR):20.57

Loading ...

Pfizer CEO warns German investment at risk over drug pricing policies

Reuters
·
Jun 10

Pfizer CEO Says Germany's Current Policies Targeting Pharma Sector Altering Pricing and Market Conditions - Letter to Chancellor Merz

THOMSON REUTERS
·
Jun 10

RBC Upgrades Pfizer to Sector Perform from Underperform, PT is $25

MT Newswires Live
·
Jun 10

Pfizer : RBC Raises to Sector Perform From Underperform

THOMSON REUTERS
·
Jun 10

Pfizer upgraded to Sector Perform from Underperform at RBC Capital

TIPRANKS
·
Jun 10

Pfizer publishes transcript from Goldman Sachs Global Healthcare Conference presentation

Reuters
·
Jun 09

BREAKINGVIEWS-GSK’s $11 bln cancer punt is worth the risk

Reuters
·
Jun 09

Bellevue says obesity, diabetes drug market shifts focus to patient adherence at ADA 2026

Reuters
·
Jun 09

Pfizer Obesity Franchise Shows Promise but Competition, Execution Risks Keep Rating at Hold and Price Target Unchanged at $26

TIPRANKS
·
Jun 09

BREAKINGVIEWS-Pentagon casts dark cloud over China biotech

Reuters
·
Jun 09

FDA Grants Approval for Pfizer's Pediatric Hemophilia Treatment

Deep News
·
Jun 09

Pfizer-Backed EV-309 Trial Targets Bladder-Sparing Edge in Muscle-Invasive Cancer

TIPRANKS
·
Jun 09

Pfizer publishes transcript of Pflash Live from ADA: Spotlight on Obesity event

Reuters
·
Jun 09

Analysts Have Conflicting Sentiments on These Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Pfizer (PFE)

TIPRANKS
·
Jun 08

Pfizer Says US FDA Expands Hemophilia Drug Approval to Younger Patients

MT Newswires Live
·
Jun 08

BUZZ-Street View: Pfizer's monthly obesity shot awaits key late-stage study results

Reuters
·
Jun 08

CORRECTED-US FDA approves Pfizer's bleeding disorder drug for children

Reuters
·
Jun 08

BRIEF-U.S. FDA Approves Pfizer’S Hympavzi For The Treatment Of Two Additional Hemophilia A Or B Patient Populations With Significant Medical Need

Reuters
·
Jun 08

FDA approves expanded US label for Pfizer hemophilia drug Hympavzi

Reuters
·
Jun 08

Pfizer - FDA Approves Expanded Indication for Pfizer's Hympavzi in Hemophilia a or B

THOMSON REUTERS
·
Jun 08